Jens Juul Holst

163k citations
2.1k papers · 136.1k · 40 hit papers · h-index 175

Impact in

Papers in

Jens Juul Holst

2k papers receiving 130.2k citations

Jens Juul Holst's Hit Papers

Glucose-dependent insulinotropic polypeptide (GIP) 2025 · 47 citations
470+2+5Years since publication4008001.2k

Peers

Jens Juul Holst
Comparison fields: 5 of 189
  • Endocrinology, Diabetes and Metabolism 55.3k
  • Endocrine and Autonomic Systems 15.6k
  • Nutrition and Dietetics 9.8k
  • Surgery 31.5k
  • Gastroenterology 4.8k
Replace Daniel J. Drucker with:
Daniel J. Drucker Canada
Stephen Robert Bloom United Kingdom
George A. Bray United States
Yūji Matsuzawa Japan
Jeffrey S. Flier United States
Robert H. Eckel United States
Gerald I. Shulman United States
Michael Horowitz Australia
Matti I.J. Uusitupa Finland
Johan H. Auwerx Switzerland
Jens Juul Holst relative to Daniel J. Drucker Canada Daniel J. Drucker's profile →
Citations per field
00.5×2×3×3.8×
Daniel J. Drucker · 1×
Citations per year

Countries citing papers authored by Jens Juul Holst

Since Specialization
Citations

This map shows the geographic impact of Jens Juul Holst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Juul Holst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Juul Holst more than expected).

Fields of papers citing papers by Jens Juul Holst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Juul Holst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Juul Holst. The network helps show where Jens Juul Holst may publish in the future.

Co-authors

The 25 scholars most cited alongside Jens Juul Holst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jens Juul Holst Line = papers co-authored together Jens Juul Holst links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 2.1k papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Physiology of Glucagon-like Peptide 1
Hit paper breakdown →
20072755
2
Type 2 diabetes mellitus
Hit paper breakdown →
20151811
3
Glucagon-like peptide 1 (GLP-1)
Hit paper breakdown →
20191455
4
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Hit paper breakdown →
19931419
5
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Hit paper breakdown →
19981169
6
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study
Hit paper breakdown →
20021110
7
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
Hit paper breakdown →
1993963
8
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Hit paper breakdown →
2017844
9 2002824
10
Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Hit paper breakdown →
1994809
11
Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations
Hit paper breakdown →
2006789
12
Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus
Hit paper breakdown →
1992769
13
Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects
Hit paper breakdown →
1995759
14
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients
Hit paper breakdown →
2001750
15
Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients
Hit paper breakdown →
2001746
16
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo
Hit paper breakdown →
1995707
17
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
Hit paper breakdown →
1997702
18 2004596
19
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
Hit paper breakdown →
1993572
20 1997559

About Jens Juul Holst

Jens Juul Holst is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Nutrition and Dietetics, having authored 2.1k papers that have together received 136.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (733 papers), Pancreatic function and diabetes (541 papers), Neuropeptides and Animal Physiology (246 papers), Regulation of Appetite and Obesity (222 papers), Bariatric Surgery and Outcomes (146 papers), Gastrointestinal motility and disorders (102 papers), Diabetes Management and Research (98 papers) and Clinical Nutrition and Gastroenterology (91 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (55.3k citations), Endocrine and Autonomic Systems (15.6k citations), Nutrition and Dietetics (9.8k citations), Surgery (31.5k citations) and Gastroenterology (4.8k citations). Jens Juul Holst has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Carolyn Fiona Deacon, Sten Madsbad, Cathrine Ørskov, Tina Vilsbøll, Michael Albrecht Nauck, Bolette Hartmann, Filip Krag Knop, Thure Krarup, Arne Vernon Astrup and Bo Åhrén. Their work appears in journals such as Diabetes, The Journal of Clinical Endocrinology & Metabolism, Diabetologia, Regulatory Peptides and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact